CARE Ratings IPO GMP History
CARE Ratings IPO has been listed on December 26, 2012 at a listing price of ₹940, against the issue price of ₹750 — a gain of ₹190 (+25.33%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
CARE Ratings IPO raised ₹539.98 Cr. through its IPO at a price band of ₹700 to ₹750 per share, with a lot size of 20 shares. The IPO was open for subscription from 07 Dec 2012 to 11 Dec 2012.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
CARE Ratings IPO dates
Key dates from opening to listing. Today is 14 November.
- Open 07 Dec 2012
- Close 11 Dec 2012
- Allotment 20 Dec 2012
- Refund/credit TBA
- Listing 26 Dec 2012
CARE Ratings IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹750 |
|---|---|
| Listing gain / loss | +₹190 per share |
| Listing date | 26 Dec, 2012 |
| Actual listing price | ₹940 (+25.33%) |
Is CARE Ratings IPO GMP reliable?
Grey market premium for CARE Ratings IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the CARE Ratings IPO full review for a fundamentals-based assessment before making any grey market trades.
CARE Ratings IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for CARE Ratings IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About CARE Ratings IPO
Credit Analysis & Research Limited is the second largest full service credit rating company in India. It has no identifiable promoter.
It offers ratings and gradings across a wide range of instruments and industries, including IPO grading, equity grading, and grading of shipyards, maritime training institutes, construction companies and real estate projects.
It also provides general and customised industry research.
The IPO was Rs 539.98 crore and was entirely an offer for sale by existing shareholders at Rs 750, the top of the Rs 700 to Rs 750 band, so the company received no money.
Frequently asked
What is the GMP of CARE Ratings IPO?
The current Grey Market Premium (GMP) of CARE Ratings IPO is not yet started or active in the market.
What is the Kostak Price of CARE Ratings IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for CARE Ratings IPO is not available.
What is the Subject to Sauda Price of CARE Ratings IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of CARE Ratings IPO?
CARE Ratings IPO listed on December 26, 2012 at ₹940, against the issue price of ₹750 — a gain of +25.33%.
How did the GMP of CARE Ratings IPO trend before listing?
The GMP of CARE Ratings IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore CARE Ratings IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
